Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

5-1-2016

Detection of respiratory viruses and bacteria in children using a
twenty-two target reverse-transcription real-time PCR (RT-qPCR)
panel
Chelsey Ellis
Children's Hospital of Eastern Ontario, Ottawa

Amita Misir
Children's Hospital of Eastern Ontario, Ottawa, amita.misir@lhsc.on.ca

Charles Hui
Children's Hospital of Eastern Ontario, Ottawa

Mona Jabbour
Children's Hospital of Eastern Ontario, Ottawa

Nicholas Barrowman
Children's Hospital of Eastern Ontario, Ottawa

See next page for additional authors

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub

Citation of this paper:
Ellis, Chelsey; Misir, Amita; Hui, Charles; Jabbour, Mona; Barrowman, Nicholas; Langill, Jonathan; Bowes,
Jennifer; and Slinger, Robert, "Detection of respiratory viruses and bacteria in children using a twenty-two
target reverse-transcription real-time PCR (RT-qPCR) panel" (2016). Paediatrics Publications. 1785.
https://ir.lib.uwo.ca/paedpub/1785

Authors
Chelsey Ellis, Amita Misir, Charles Hui, Mona Jabbour, Nicholas Barrowman, Jonathan Langill, Jennifer
Bowes, and Robert Slinger

This article is available at Scholarship@Western: https://ir.lib.uwo.ca/paedpub/1785

Pediatric respiratory infection RT-qPCR panel

Detection of respiratory viruses and bacteria in children
using a twenty-two target reverse-transcription real-time
PCR (RT-qPCR) panel
Chelsey Ellis, Amita Misir, Charles Hui, Mona Jabbour, Nicholas Barrowman, Jonathan
Langill, Jennifer Bowes, Robert Slinger
Ottawa, Canada

Methods: RT-qPCR assays for twenty-two target
organisms were dried-down in individual wells of 96 well
plates and saved at room temperature. Targets included 18
respiratory viruses and 4 bacteria. After automated nucleic
acid extraction of nasopharyngeal aspirate (NPA) samples,
rapid qPCR was performed. RT-qPCR results were
compared with those obtained by the testing methods
used at our hospital laboratories.
Results: One hundred fifty-nine pediatric NPA samples
were tested with the RT-qPCR panel. One or more
respiratory pathogens were detected in 132/159 (83%)
samples. This was significantly higher than the detection
rate of standard methods (94/159, 59%) (P<0.001).
This difference was mainly due to improved RT-qPCR
detection of rhinoviruses, parainfluenza viruses, bocavirus,
and coronaviruses. The panel internal control assay
performance remained stable at room temperature storage
over a two-month testing period.
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Conclusions: The RT-qPCR panel was able to identify
pathogens in a high proportion of respiratory samples. The
panel detected more positive specimens than the methods
in use at our hospital. The pre-made panel format was easy
to use and rapid, with results available in approximately
90 minutes. We now plan to determine if use of this panel
improves patient care and antibiotic stewardship.
World J Pediatr 2016;12(2):183-189
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Introduction

A

cute respiratory infections (ARIs) represent a
significant burden to pediatric healthcare. These
rank among the top five causes of illness and
hospitalization for children, and are among the top ten
reasons for visits to the emergency departments (ED) in
the United States.[1] The burden of ARIs presents specific
challenges. Although most ARIs are caused by viruses,
up to 60% of young children with ARIs are treated with
antibacterial agents. [2] While unnecessary antibiotic
usage may be reduced through a number of approaches,
including patient and physician education,[3,4] physicians
are often pressured to treat with antibiotics.
Rapid detection of the causes of ARIs is another
potential means of improving antibiotic stewardship.
Rapid detection has been shown to reduce inappropriate
prescriptions for pharyngitis.[5] As well, a randomized
controlled trial used rapid fluorescent antibody (FA)
tests for several viruses to test pediatric ED patient
specimens demonstrated a significant reduction in
antibiotic prescription after ED discharge, as well as
a trend towards decreased post-ED discharge medical
office or ED visits.[1] The authors suggested that rapid
multi-viral testing in the ED may be a novel strategy
to alter community physician antibiotic prescription
183
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Background: Rapid detection of the wide range of
viruses and bacteria that cause respiratory infection
in children is important for patient care and antibiotic
stewardship. We therefore designed and evaluated a readyto-use 22 target respiratory infection reverse-transcription
real-time polymerase chain reaction (RT-qPCR) panel to
determine if this would improve detection of these agents at
our pediatric hospital.
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patterns. Rapid detection of respiratory pathogens
could also potentially reduce unhelpful medical tests in
children with viral respiratory infections. For example,
a Cochrane review of available studies in this field
demonstrated that rapid testing for viral infections in
the ED decreased the rate of chest radiography use.[6]
In addition to reducing unnecessary antibiotic
use and procedures, rapid tests may be benefits for
children who have atypical bacterial infections, such
as Bordetella pertussis or Mycoplasma pneumoniae,
or treatable viral infections such as influenza, although
these benefits have not yet been proven.
We therefore plan to perform a controlled trial in
which children will be randomized to rapid respiratory
infection testing or non-testing groups, and then followed
for several outcomes to see if clinical care is improved
with testing. For this future study, we considered use of
a number of molecular detection methods. Based on the
published literature, we concluded that singleplex [one
target per polymerase chain reaction (PCR) reaction],
reverse transcription real-time PCR (RT-qPCR) has so far
been shown to be more sensitive than multiplex (multiple
targets per PCR reaction) testing and also that standardvolume singleplex RT-qPCR appears to have better
sensitivity than low-volume singleplex RT-qPCR for
respiratory virus detection.[7-9]
For example, Deng et al[7] detected viral pathogens
in 45.9% of respiratory specimens using a commercial
multiplex method and in 62.6% of these specimens using
singleplex RT-qPCR assays. Gadsby et al[8] compared
three viral detection methodologies: FA and culture,
singleplex RT-qPCR assays, and another commercial
multiplex method. These investigators found at least one
respiratory viral pathogen in 13.6% of specimens by FA
and culture (combined), in 46.2% by the commercial
method, and in 49.7% by RT-qPCR.[8] The RT-qPCR
assays were considered to be the gold standard in
this paper, and the sensitivity and specificity of the
commercial multiplex method were reported as 78.8%
and 99.6%, respectively, compared with RT-qPCR.
Multiple low-volume singleplex RT-qPCR has
also been described using a 384-well format with 1 μL
reaction volumes, known as the TaqMan Array Card
(TAC). The TAC method was compared with individual
larger volume (25 μL) RT-qPCR assays, and found to
have generally lower sensitivity than the larger volume
individual RT-qPCR assays, with TAC sensitivity for
different viral targets ranging from 54% to 95%.[9] The
lower RT-qPCR volumes in the TAC may therefore
lower sensitivity somewhat compared with more
commonly used reaction volumes.
Thus, the current literature suggests that standardvolume singleplex RT-qPCR assay is the best detection
method, and we elected to use this method for our
study. However, there are disadvantages of performing
184

multiple singleplex assays. The method is laborintensive if pipetting is done manually, and plates
preparing with multiple individual RT-qPCR assays in
liquid format each time a sample is tested is also timeconsuming. We therefore sought to overcome these
barriers by using 1) dried-down assays in a pre-made
panel format, and 2) automation for sample extraction
and RT-qPCR plate preparation.
We describe below the results of an initial retrospective
evaluation of a 22 target panel containing dried-down,
ready-to-use, singleplex standard-volume RT-qPCR
assays. The panel included assays for 18 respiratory
viruses and 4 atypical respiratory bacterial agents in 96well microtiter plate format, and took approximately 90
minutes to complete.

Methods

Specimens
The study was performed at the Children's Hospital
of Eastern Ontario, a tertiary care pediatric hospital in
Ottawa, ON, Canada, with 165 beds and approximately 70
000 ED visits per year. Ethics approval was obtained by
the hospital Research Ethics Board for testing of residual
aliquots of nasopharyngeal aspirate (NPA) samples that
were otherwise to be discarded in 2011-2012.
Approximately 2 mL NPA samples were collected
and was saved at 4°C for 1 week. One mL was then saved
at -80°C prior to nucleic acid extraction for this study.
Only NPA specimens submitted for both respiratory viral
testing and testing for Bordetella pertussis and Bordetella
parapertussis were included in the study.
The MS2 bacteriophage (Zeptometrix Corp., Buffalo,
NY) was added to samples prior to extraction as a control
for extraction, reverse transcription, and amplification.
Automated sample nucleic acid extraction was then
performed using an iPrep device (Life Technologies,
Carlsbad, CA).
RT-qPCR assays
The sequences of respiratory infectious disease
RT-qPCR panel primers and probes are shown in
Supplementary Table 1. Accession numbers for the
sequences and location in the target gene or genome are
shown in Supplementary Table 2. All probes were of
the 5' exonuclease-type and contained a minor groove
binder (Life Technologies, Carlsbad, CA).
Analytical performance
For each assay, amplicon oligonucleotide sequences
(Ultramers, Integrated DNA Technologies, Coralville,
ID) were obtained to act as quantitative positive
controls. The analytical performance of the PCR assays
used in the panel was then evaluated in several ways.
World J Pediatr, Vol 12 No 2 . May 15, 2016 . www.wjpch.com
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The limit of detection (LoD) was determined using
three 10-fold serial dilutions of these oligonucleotides
and was considered to be detected if three samples were
positive. The efficiencies of the PCR assays were also
calculated by the thermocycler software from standard
curves produced from serial dilution sample testing in
triplicate. Assay repeatability (intra-assay variability) was
assessed by calculating the mean coefficient of variation
(CV) of six serially diluted samples tested duplicate on
the same PCR run. Finally, reproducibility (inter-assay
variability) was obtained by calculating the mean CV of
six serially diluted samples tested on different days.

Table 1. Comparison of respiratory infectious disease panel with
molecular methods used by other laboratories using Quality Control for
Molecular Diagnostics past panel samples
Real-time
Laboratories that detected
Organism
PCR panel
agent in specimen (%)
Results for the lowest concentration Proficiency testing specimen
Influenza A, H3
Detected
54.9
Influenza B
Detected
25.0
RSV A
Detected
72.4
RSV B
Detected
84.8
Human metapneumovirus A Detected
97.1
Human metapneumovirus B Detected
95.2
Coronavirus NL63
Detected
72.5
Coronavirus OC43
Detected
77.5
Human adenovirus 4
Detected
75.5
Rhinovirus 16
Detected
40.0
Parainfluenzae 1
Detected
65.7
Parainfluenzae 2
Detected
85.7
Parainfluenzae 3
Detected
91.4
Parainfluenzae 4
Detected
45.7
Coxsackievirus A9
Detected
91.9
Echovirus 11
Detected
99.5
Bordetella pertussis
Detected
62.1
Bordetella parapertussis
Detected
NA
Chlamydophila pneumoniae Detected
100.0
Influenza A, H1
Not detected 21.1
Rhinovirus 90
Not detected 38.0
Coronavirus 229E
Not detected 22.5
Mycoplasma pneumoniae
Not detected 72.6
Results for the 2nd lowest concentration Proficiency testing specimen
Influenza A, H1
Detected
63.4
Rhinovirus 90
Detected
88.0
Coronavirus 229E
Detected
87.5
Mycoplasma pneumoniae
Detected
93.7
RT-qPCR: reverse transcription real-time polymerase chain reaction;
RSV: respiratory syncytial virus; NA: not available.
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Molecular proficiency testing specimen evaluation
Since a number of commercial and non-commercial
molecular methods are now used for detection of
respiratory agents, we wished to compare the performance
of the assays in the panel with those obtained using other
molecular methods. Molecular proficiency testing samples
[Quality Control for Molecular Diagnostics Samples
(QCMD) Past Panels (Qnostics, Glasgow, UK)] were
therefore studied. These panels contain serially diluted
mock samples and provided a means of comparing the
RT-qPCR singleplex assay results with those obtained by
a large number of participating laboratories using a range
of molecular detection methods. Past panels tested were:
QCMDBPDNA09 (Bordetella pertussis and Bordetella
parapertussis), CP.MP09 (Chlamydophila pneumoniae and
Mycoplasma pneumoniae), QCMDINFRNA09 (influenza
viruses), QCMDEVRNA09 (enteroviruses), MPV.
RSV08 (metapneumoviruses and respiratory syncytial
viruses), ADVDNA07 (adenoviruses), PINFRNA06
(parainfluenza viruses), and RV.CVRNA07 (rhinoviruses
and coronaviruses). For two of the targets, bocavirus
and coronavirus HKU1, proficiency testing samples
were unavailable, so the performance of these assays in
comparison with other laboratories could not be assessed.

Table 2. Comparison of the respiratory infectious disease RT-qPCR
panel with standard methods (specimens were considered to be positive
if 1 organism was detected)
Standard test
Standard test
Specimens
Total
positive
negative
PCR panel positive 91
41
132
PCR panel negative 3
24
27
Totals
94
65
159
RT-qPCR: reverse transcription real-time polymerase chain reaction.
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Specificity
qPCR assay specificity was tested in several ways.
Primer and probe specificity was initially checked in
silico by searching GenBank sequences for matches to
the primers and probes using the BLAST tool.
We tested assay specificity in vitro against nucleic
acid extracted from a number of viruses and bacteria.
Viruses tested were respiratory syncytial virus (RSV)
A and B, influenza A and B, metapneumovirus A and
B, rhinoviruses, coronaviruses OC43, NL63, 229E,

enteroviruses, parainfluenza viruses 1, 2, 3 and 4,
adenoviruses. As coronavirus HKU1 and bocavirus
were not available to us, the synthetic oligonucleotides
mentioned above were used for specificity testing. The
bacteria tested were Bordetella pertussis, Bordetella
parapertussis, Mycoplasma pneumoniae, Chlamydophila
pneumoniae, Streptococcus pneumoniae. American
type culture collection (ATCC) 49619, Streptococcus
salivarius ATCC 13419, Escherichia coli ATCC 25922,
Haemophilus influenzae ATCC 49766, Haemophilus
influenzae ATCC 49247, Haemophilus parainfluenzae
ATCC 7901, Klebsiella pneumoniae ATCC 700603,
Moraxella catarrhalis ATCC 25238, Staphylococcus
aureus ATCC 29247, Neisseria gonorrhoeae ATCC
49226, Neisseria lactamica ATCC 23970, Pseudomonas
aeruginosa ATCC 27853, Enterococcus faecalis ATCC
29212, Streptococcus dysgalactiae subsp. equisimilis,
Streptococcus agalactiae, Streptococcus intermedius,
Streptococcus constellatus, and Streptococcus anginosus.
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RSV
Metapneumoviruses
Rhinoviruses
Parainfluenza virus
Coronaviruses
Influenza virus
Mycoplasma
Bordetella pertussis
Bocavirus
Adenoviruses
Enterovirus

Fig. 1. Reverse-transcription real-time polymerase chain reaction
(RT-qPCR) panel: viral and bacterial organisms detected (n=160).
For some viruses, the RT-qPCR panel differentiated viral species or
subtypes. For respiratory syncytial virus (RSV), there were 33 RSV
A, and 28 RSV B; for influenza, 4 influenza A, and 2 influenza B; for
metapneumoviruses, 9 metapneumovirus A, and 5 metapneumovirus B;
for parainfluenza viruses (PIV), 5 PIV1, 1 PIV2, 5 PIV3, and 1 PIV4;
and for coronaviruses, 2 OC43, 2 NL63, and 2 HKU1.
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qPCR was performed in 20 μL volume, using a one-step
rapid reverse transcriptase master mix for all reactions
(TaqMan FAST Viral master mix, Life Technologies,
Carlsbad, CA). Liquid wax (Chill-out™ Liquid Wax,
Bio-Rad Canada, Mississauga, ON) was dispensed into
each well by the liquid handler to act as a vapor barrier.
Thermocycling was performed using a ViiA7 realtime PCR device (Life Technologies, Carlsbad, CA) in
a fast mode. Initially, a temperature of 50°C was held
for 5 minutes for reverse transcription, followed by 40
cycles of two-temperature cycling at 95°C for 3 seconds
followed by 60°C for 30 seconds, with a final cooling
stage to 5°C to harden the liquid wax, resulting in sealed
microtiter wells. RT-qPCR results were interpreted with
the proprietary software of a ViiA7 thermocycler and then
exported to Microsoft Excel 2010 for further analysis. The
ViiA7 software default threshold set at 0.35 arbitrary units
was used for determination of cycle threshold values. RTqPCR results with cycle threshold values of ≤33 cycles
were considered as positive.
Room temperature stability
RT-qPCR panel plates were saved at room temperature
until use, in accordance with manufacturer's
recommendations. We anticipated that the cycle threshold
values for the MS2 control assay would increase over
time if the assay deteriorated when stored at room
temperature. We therefore assessed room temperature
stability by statistically comparing the control cycle
threshold values over time. Four clinical NPA samples
were tested daily 5 days per week (Monday-Friday). The
mean threshold cycle value for the samples tested each
day was calculated and recorded. The daily mean values
obtained over the two month testing period were plotted
vs. time and compared statistically as described below.

70
Number of positive nasopharygeal aspirate specimens

Original article

Clinical specimen evaluation with the RT-qPCR panel
Following these initial evaluations, the assays
were manufactured, inserted into wells in 96-well
microAmp fast RT-qPCR plates, and dried-down by the
manufacturer (Life Technologies, Carlsbad, CA) using
a proprietary process. Target and control assays were
laid out in 3 columns of 8 wells each. Thus, a maximum
of four specimens can be tested per plate.
NPA samples described above were then tested with
the RT-qPCR panel. Results obtained were then compared
with the standard testing methods used by the hospital
clinical laboratories. The standard tests were FA testing
for respiratory syncytial virus, influenza, and metapneumovirus, viral culture, and RT-qPCR for Bordetella
pertussis and Bordetella parapertussis (some specimens
were also tested for Mycoplasma pneumoniae by PCR by
the clinical laboratory).
Two control wells were tested with each specimen.
These contained an assay for amplification of the MS2
target that had been added to each sample prior to
nucleic acid extraction that served as a positive reaction
control. A positive reaction in this well indicated
successful extraction of the MS2 RNA as well as that
inhibition reverse transcription and PCR amplification
had not occurred. We also included a well containing
the same MS2 assay with master mix and water as a "no
template" control for contamination, in that a positive
reaction would indicate specimen nucleic acid had
contaminated this well during plate preparation.
The sample and master mix were added to the RTqPCR plate using an automated liquid handling device
(Eppendorf 5070, Eppendorf, Mississauga, ON). RT-
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Fig. 2. Comparison of respiratory infectious disease reverse-transcription
real-time polymerase chain reaction (RT-qPCR) panel viral and bacterial
organism detection with standard methods. RSV: respiratory syncytial virus.
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Results

Analytical performance characteristics of PCR assays
are shown in Supplementary Table 2. As shown, the
LoD of the assays ranged from 1 to 100 copies per PCR
reaction, and the assay efficiencies were all >90%. In
terms of repeatability, the mean intra-assay CVs ranged
from 0.33 to 4.02, and the reproducibility or inter-assay
CVs from 0.99 to 5.98.
Specificity of the assays was also acceptable, as we
did not observe cross-reactions with other viral or bacterial
organisms tested for in the panel or with the non-target
organisms. Based on these results, the performance of
the respiratory infectious disease panel was judged as
acceptable for use in the clinical specimen study.
Results of the comparison of the respiratory infectious
disease RT-qPCR assays to the proportion of correct results
from laboratories participating in the molecular proficiency
studies are shown in Table 1. As seen, specimen with the
lowest concentration of target in the proficiency panel
could be detected by the respiratory infectious disease
panel assay for 18/22 (82%) of organisms tested. For
the four lowest concentration samples that were not
detected by the panel assay, the proportion of laboratories
able to detect the organism in the same samples using other
methods was generally low (Table 1). All four organisms
were detected by the PCR panel using the second lowest
concentration samples.
One hundred fifty-nine pediatric NPA samples
were then tested with the respiratory infectious disease
panel. The panel detected one or more of the target
organisms in 132/159 (83%) of these samples. This was
significantly higher than the detection rate of standard
methods (94/159, 59.1%) (P<0.001). Detection of
any pathogen (≥1) in the NPA specimens by the two
methods is shown in Table 2.
The relative distributions of the agents detected
by the respiratory infectious disease panel are shown
in Fig. 1. As seen, RSV was the most common agent
World J Pediatr, Vol 12 No 2 . May 15, 2016 . www.wjpch.com

detected. Both RSV type A (33 specimens) and B
(28 specimens) were detected. Rhinoviruses were the
second most common organism detected, followed by
meta-pneumoviruses and then bocaviruses.
Inhibition of amplification, defined by absence of
MS2 control assay amplification in the specimen, was
not observed in any samples. As well, none of the "no
template" reaction wells showed amplification of MS2,
indicating that cross-contamination did not occur.
Fig. 2 compares the detection of organisms by RTqPCR and standard methods. In total, 159 organisms
were detected in the 132 RT-qPCR positive specimens,
while 95 organisms were detected in the 94 samples
positive by standard testing methods. Eighty-two
percent (108/132) of RT-qPCR positive samples
had a single organism detected, 21/132 (15.9%) had
two organisms detected, and 3/132 (2.3%) samples
contained three organisms. Only one sample was
reported to have two organisms by standard testing.
RT-qPCR detected 86 of the 95 organisms detected
by standard testing as well as 73 additional organisms
not detected by standard methods, whereas standard
methods detected 9 organisms not detected by RTqPCR. Among the 73 organisms detected by RT-qPCR
but not standard methods there were a large number
of rhinoviruses: 26 specimens were found to contain
rhinoviruses by RT-qPCR and only 3 specimens by
viral culture. RSV and parainfluenza viruses were also
detected more frequently by RT-qPCR than by standard
methods. Bocaviruses and coronaviruses, viruses that
cannot be grown in viral culture, were also detected by
RT-qPCR in several specimens.
Among the nine organisms detected by standard
methods but not by RT-qPCR were 3 samples reported
to contain enterovirus by culture. These samples
were tested positive for rhinovirus but negative for
enterovirus with the RT-qPCR panel. The other samples
reported as positive by standard methods but not
by RT-qPCR consisted of: 2 RSV, 2 rhinoviruses, 1
Mycoplasma pneumoniae, and 1 Bordetella pertussis.
With respect to the assessment of room temperature
stability, regression analysis of the cycle threshold
values for the MS2 control target showed that the slope
of the regression line did not differ significantly from
zero over the two-month period that the PCR plates were
used (P=0.30). This suggests the stability of the panels with
room temperature storage over this time frame.

Discussion

The respiratory infectious disease multiple-target
singleplex RT-qPCR panel detected respiratory viral and
bacterial pathogens in a significantly higher proportion
of pediatric NPA samples than the standard methods used
187
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Statistical analysis
Given that singleplex RT-qPCR is widely accepted as
the reference standard for respiratory viral specimen
testing,[7-9] results were considered as true positives
if positive by standard tests or if positive with the
respiratory infectious disease RT-qPCR panel.
The McNemar test was then used to compare
differences between the respiratory infectious disease
panel and the standard tests. For room temperature stability
assessment, threshold values over time were plotted and
robust linear regression (Huber M-estimation) was used
to determine whether the slope was significantly different
from zero.[22] Two-sided P values less than 0.05 were
deemed to be statistically significant.
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by our hospital laboratories. As well, the proportion of
positive specimens detected with the respiratory infectious
disease RT-qPCR panel (83%) was similar to or higher
than that reported for other molecular methods.[7-9]
The PCR assays used in the RT-qPCR panel appeared
to have acceptable performance characteristics, and also
performed well relative to other molecular methods
used in molecular proficiency testing studies. However,
other laboratories may prefer to use other assays in
similar panels; a major advantage of use of multiple-target
singleplex testing is that since each assay is independent,
one assay can be replaced with another without affecting
the performance of all other assays in the panel. This is in
contrast to multiplex single well assays where a change in
one assay may adversely affect the performance of other
assays, thus requiring extensive laboratory re-testing of
the method if any assay changes are made.
The method devised can be completed in approximately
90 minutes, a shorter test time than many commercially
available other multiple-target tests. With this time, it may
be feasible to test patients and obtain results while patients
are still present in the ED, provided such testing is linked
to a strategy of obtaining samples immediately upon the
patient's arrival to the ED.
Another potential advantage of the RT-qPCR method
we used is that it can be used to quantify the amount of
pathogen present in the specimen. The quantity of virus
present has been shown to correlate with disease severity
for a number of viruses including RSV, bocaviruses, and
rhinoviruses.[23-25] Although not examined as part of this
study, quantification may become an important tool in
the future, as this could potentially be used to help predict
patients at risk for more severe disease who may therefore
require hospital admission or intensive care unit admission.
There are several limitations to our pilot study. First,
it was retrospective, so we have not yet demonstrated
prospectively that results can be obtained while patients are
still present in our ED. Another limitation in comparison
is that not all NPA samples were tested for Mycoplasma
pneumoniae in the clinical laboratory. Therefore, we are
unable to directly compare the current clinical lab RTqPCR to that contained in the respiratory infectious disease
panel. A technical limitation is that the method is semiautomated but not fully automated, and still requires handson personnel involvement to move samples from the
extraction device to the liquid handler and from the liquid
handler to the thermocycler. Our evaluation of the stability
of the PCR assays in the panel was also a limitation,
since for logistic and financial reasons, we were able to
assess the stability of the control assay for up to a 2-month
period only, and we did not evaluate if the assay remained
stable beyond this time period. We also did not assess the
stability of all PCR assays. The maximum length of time is
determined for dried-down assays which remain stable at
188

room temperature in RT-qPCR panels in the future.
Also, we were unable to directly compare our
method with other multiplex or multiple target molecular
methods, and instead compared the RT-qPCR panel with
the standard methods used in our clinical laboratories.
Some of the standard methods are known to have
limitations. FA is generally reported to have a relatively
high sensitivity for RSV detection but a poorer sensitivity
for other viruses.[19] Viral culture methods have a poor
sensitivity for some respiratory viruses. For example,
metapneumoviruses, bocaviruses, and coronavirues
cannot be isolated using common viral culture methods.
Although rhinoviruses can be grown in culture, RTqPCR is generally a more sensitive detection method
for this group of viruses, as seen in this study. A future
comparison of our method with one or more other
molecular multiple target methods would be useful.
Finally, we observed discordant results between RTqPCR and culture for three samples that were reported to
contain enterovirus by culture but gave positive results for
rhinovirus and negative results for enterovirus by PCR. Of
note, enteroviruses and rhinoviruses are related members
of the Picornaviridae family of viruses. We did not
observe cross-reactivity with any of the tested rhinovirus
or enterovirus strains used in initial studies of the panel.
We plan to further investigate these discordant results to
determine if the culture or PCR identification is correct.
In summary, we were able to demonstrate detection of a
large number of respiratory viruses and bacteria in pediatric
specimens using the "gold standard" detection approach of
singleplex standard-volume RT-qPCR using a ready-to-use
panel and a rapid semi-automated method. This approach
may be an attractive alternative to other multiple target
molecular methods for detection of respiratory pathogens.
The potential clinical and public health advantages
of multiple-target detection panels are numerous.
Rapid initiation of appropriate antibacterial or antiviral
treatment should help reduce morbidity caused by the
infectious agent. Better antibiotic stewardship may also
be achieved, since reduction of unnecessary antibiotic
use will help prevent both adverse outcomes due to
antibiotics such as allergic reactions or development of
Clostridium difficile diarrhea.[26] The development of
antibiotic-resistant bacterial organisms from improper
antibiotic prescribing may also decrease.[27]
Finally, health care costs might be lowered by decreasing
antibiotic costs, reducing unneeded blood tests and diagnostic
imaging procedures, and reducing patient length of stay
in the ED. Additional health care visits for the illness
might also decrease if a diagnosis of a specific infectious
agent could be provided to parents and physicians.
We believe that randomized clinical trials are needed
to determine if rapid molecular testing for respiratory
infections in children leads to improved outcomes.
World J Pediatr, Vol 12 No 2 . May 15, 2016 . www.wjpch.com
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